Article: InterMune Announces Fourth Quarter and Full Year 2006 Financial Results.

Fourth Quarter and Full Year Non-GAAP Net Loss Results Improve

BRISBANE, Calif., Feb. 8 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced results from operations for the fourth quarter and year ended December 31, 2006.

As a result of the December 30, 2005, divestiture of Infergen(R) and in compliance with U.S. Generally Accepted Accounting Principals (GAAP), revenue and operating costs associated with Infergen(R) are reported in discontinued operations in the company's financial statements.

Results for the Fourth Quarter 2006

InterMune reported a net loss for the fourth quarter of 2006 of $16.6 million, or $0.49 per share, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!